|
|
|
|
||
Re: Added Definitely seems like a good buying point now (though I've been wrong before). Cash value; plus LNP royalties from Alny; plus value to Genevant; plus future potential HBV cure add up to a lot more than $1.57. While I agree that golden parachutes might be expensive there is no indication that this will happen - at least in the near term. GLTA - what a change 1 year can make! (both for the worse and the better). |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
34629 | Re: Added | RestD | 1 | 6/12/2019 10:44:04 AM |
34635 | Re: Added | evernewbliss | 3 | 6/15/2019 12:41:11 PM |